Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne Yndestad

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Journal of the American College of Cardiology|August 29, 2009
Testosterone: a novel therapeutic approach in chronic heart failure?Pål Aukrust, Thor Ueland, Lars Gullestad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Therapeutic potential of anticytokine therapy in congestive heart failurePal Aukrust, Arne Yndestad, Jan K Damås, et al.
Autoimmunity Reviews|April 28, 2004
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulinPål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
Fundamental & Clinical Pharmacology|November 16, 2007
The role of statins in heart failureLars Gullestad, Erik Oie, Thor Ueland, et al.
Current Heart Failure Reports|March 29, 2012
TNF revisited: osteoprotegerin and TNF-related molecules in heart failureThor Ueland, Arne Yndestad, Christen P Dahl, et al.
Annals of Medicine|July 20, 2005
Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implicationsPål Aukrust, Lars Gullestad, Thor Ueland, et al.
Heart Failure Monitor|March 21, 2006
Anti-inflammatory trials in chronic heart failurePål Aukrust, Arne Yndestad, Thor Ueland, et al.
Vitamins and Hormones|March 1, 2011
Activin A in nonalcoholic fatty liver diseaseArne Yndestad, John Willy Haukeland, Tuva B Dahl, et al.
Journal of the American College of Cardiology|October 9, 2007
T cells in coronary artery disease: different effects of different T-cell subsetsPål Aukrust, Arne Yndestad, Wiggo J Sandberg, et al.
Rheumatology and Therapy|March 17, 2025
A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical TrialsGrace C Wright, Eduardo Mysler, Arne Yndestad, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Journal of the American College of Cardiology|August 29, 2009
Testosterone: a novel therapeutic approach in chronic heart failure?Pål Aukrust, Thor Ueland, Lars Gullestad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Therapeutic potential of anticytokine therapy in congestive heart failurePal Aukrust, Arne Yndestad, Jan K Damås, et al.
Autoimmunity Reviews|April 28, 2004
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulinPål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
Fundamental & Clinical Pharmacology|November 16, 2007
The role of statins in heart failureLars Gullestad, Erik Oie, Thor Ueland, et al.
Current Heart Failure Reports|March 29, 2012
TNF revisited: osteoprotegerin and TNF-related molecules in heart failureThor Ueland, Arne Yndestad, Christen P Dahl, et al.
Annals of Medicine|July 20, 2005
Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implicationsPål Aukrust, Lars Gullestad, Thor Ueland, et al.
Heart Failure Monitor|March 21, 2006
Anti-inflammatory trials in chronic heart failurePål Aukrust, Arne Yndestad, Thor Ueland, et al.
Vitamins and Hormones|March 1, 2011
Activin A in nonalcoholic fatty liver diseaseArne Yndestad, John Willy Haukeland, Tuva B Dahl, et al.
Journal of the American College of Cardiology|October 9, 2007
T cells in coronary artery disease: different effects of different T-cell subsetsPål Aukrust, Arne Yndestad, Wiggo J Sandberg, et al.
Rheumatology and Therapy|March 17, 2025
A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical TrialsGrace C Wright, Eduardo Mysler, Arne Yndestad, et al.
Pageof 20